 | |
| Clinical data | |
|---|---|
| Trade names | Ultravate |
| Other names | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one, halobetasol (USANUS) |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a601060 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H27ClF2O4 |
| Molar mass | 428.90 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Ulobetasol (INN) orhalobetasol (USAN) is acorticosteroid used to treatpsoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4]
Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed] It is also sold withtazarotene with 0.01% halobetasol and 0.045%tazarotene as a lotion branded asDuobrii (Bausch Health).
It is available as ageneric medication.[5]
 | Thisdermatologicdrug article is astub. You can help Wikipedia byexpanding it. |
